| Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010. | |
| | |
MedLine Citation:
|
PMID: 21232023 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The 2010 7th International Melanoma Congress sponsored by the Society for Melanoma Research and held in Sydney, Australia, was held together with the International Melanoma and Skin Cancer Centers group and the International Melanoma Pathology Study Group. As a consequence, there were over 900 registrants that included a wide range of clinicians (surgeons, medical oncologists, dermatologists) specialising in the management of melanoma as well as scientists and students carrying out laboratory-based research in melanoma. There was a general consensus that this grouping of clinicians, pathologists and scientists was mutually advantageous and plans are afoot to continue this grouping in future meetings. The meeting was dominated by the advances being made in treatment of melanoma with selective BRAF inhibitors but interest in epithelial mesenchymal transition and phenotypic changes in melanoma was apparent in many of the talks. The authors have attempted to capture many of the new developments in melanoma research but apologize to those speakers and poster presenters who had equally important findings not captured in these summaries. |
| | |
Authors:
|
P Hersey; K S M Smalley; A Weeraratna; M Bosenberg; X D Zhang; N K Haass; E Paton; G Mann; R A Scolyer; T Tüting |
Related Documents
:
|
6980683 - Male carriage of gardnerella vaginalis. 22059253 - Criminal sittings – rape in the colony, new zealand, 1862. 20094933 - Using multidisciplinary teams to address ethical dilemmas with older adults who hoard. |
Publication Detail:
|
Type: Congresses Date: 2010-12-22 |
Journal Detail:
|
Title: Pigment cell & melanoma research Volume: 24 ISSN: 1755-148X ISO Abbreviation: Pigment Cell Melanoma Res Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-01-14 Completed Date: 2011-04-22 Revised Date: 2011-11-10 |
Medline Journal Info:
|
Nlm Unique ID: 101318927 Medline TA: Pigment Cell Melanoma Res Country: England |
Other Details:
|
Languages: eng Pagination: e1-15 Citation Subset: IM |
Copyright Information:
|
© 2010 John Wiley & Sons A/S. |
Affiliation:
|
Peter.Hersey@newcastle.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Clinical Trials as Topic Congresses as Topic* Disease Models, Animal Drug Screening Assays, Antitumor Humans Immunotherapy Melanoma / drug therapy, genetics, pathology*, therapy Mice Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors, metabolism Neoplastic Stem Cells / drug effects, pathology New South Wales Protein Kinase Inhibitors / pharmacology, therapeutic use Proto-Oncogene Proteins B-raf / antagonists & inhibitors, metabolism Zebrafish / genetics |
| Chemical | |
Reg. No./Substance:
|
0/Protein Kinase Inhibitors; EC 2.7.1.37/BRAF protein, human; EC 2.7.11.1/Proto-Oncogene Proteins B-raf; EC 2.7.12.2/Mitogen-Activated Protein Kinase Kinases |
| Comments/Corrections | |
Comment In:
|
Pigment Cell Melanoma Res. 2011 Feb;24(1):107-9
[PMID:
21232025
]
|
Erratum In:
|
Pigment Cell Melanoma Res. 2011 Oct;24(5):989 Note: Tüting, T [added] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tacrine Treatment at High Dose Suppresses the Recognition Memory in Juvenile and Adult Mice with Att...
Next Document: In vitro differentiation of retinal pigment epithelium from adult retinal stem cells.